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Abstract
Inefficient thymic negative selection of self-specific T cells is associated with several autoimmune
diseases, including type 1 diabetes (T1D). The factors that influence the efficacy of thymic
negative selection, and the kinetics of thymic output of autoreactive T cells remain ill-defined. We
investigated thymic production of β cell-specific T cells using a thymus transplantation model.
Thymi from different aged NOD mice representing distinct stages of T1D, were implanted into
NOD.scid recipients and the diabetogenicity of the resulting T cell pool examined. Strikingly, the
development of diabetes-inducing β cell-specific CD4+ and CD8+ T cells was regulated in an age-
dependent manner. NOD.scid recipients of newborn NOD thymi developed diabetes. However,
recipients of thymi from 7 and 10 d-old NOD donor mice remained diabetes-free, and exhibited a
progressive decline in islet infiltration and β cell-specific CD4+ and CD8+ T cells. A similar
temporal decrease in autoimmune infiltration was detected in some but not all tissues of recipient
mice implanted with thymi from NOD mice lacking expression of the autoimmune regulator
transcription factor, which develop multi-organ T cell-mediated autoimmunity. In contrast,
recipients of 10 d or older thymi lacked diabetogenic T cells but developed severe colitis marked
by increased effector T cells reactive to intestinal microbiota. These results demonstrate that
thymic development of autoreactive T cells is limited to a narrow time-window, and occurs in a
reciprocal manner compared to colonic microbiota-responsive T cells in NOD mice.
INTRODUCTION
Events ongoing in the thymus play a critical role in shaping the repertoire of T cells (1, 2).
Positive selection in the thymic cortex generates a pool of T cells restricted to self-MHC
molecules. On the other hand, negative selection in the medulla of the thymus ensures that
thymocytes reactive to self-antigens are purged via induction of apoptosis or anergy (3, 4).
Medullary thymic epithelial cells (mTEC) (5-7) and dendritic cells (DC) (8-10) drive
thymocyte negative selection by expressing and/or presenting self-antigens, respectively. A
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constellation of tissue-specific antigens (TSA) is expressed by mTEC (5, 11) and expression
of many of these TSA is controlled by the autoimmune regulator (Aire) transcription factor
(5, 12, 13). The parameters that influence the efficiency of thymic negative selection are ill-
defined, but are believed to include the avidity of the interaction of thymocytes with mTEC
and DC, intrinsic responses of thymocytes to apoptosis induction, and/or levels of thymic
TSA expression and presentation (14-18).
Inefficient thymic negative selection has been associated with various T cell-mediated
autoimmune diseases such as type 1 diabetes (T1D) (3, 19, 20). T1D in humans and rodent
models, such as the NOD mouse, is characterized by the CD4+ and CD8+ T cell-mediated
destruction of the insulin-producing β cells residing in the pancreatic islets of Langerhans
(21). In NOD mice the diabetogenic response involves progressive insulitis in which T cells
and other immune effectors infiltrate the islets over time. Insulitis is first detected at 3-4 wk
of age and relatively few β cell autoantigens and epitopes are targeted by CD4+ and CD8+ T
cells (22-25). By 12 wk of age, a late preclinical stage of T1D, the islets in NOD mice are
heavily infiltrated, marked by effector T cells (Teff) targeting numerous β cell autoantigens
and epitopes. Aberrant survival of islet resident Foxp3-expressing immunoregulatory CD4+
T cells (Foxp3+Treg) is then believed to promote a wave of robust β cell destruction and the
onset of overt diabetes (26, 27). NOD mice also exhibit T cell autoimmunity to other tissues
such as the thyroid (28, 29) and salivary gland (30), and low levels of colitis (31, 32) are
detected suggesting general defects in mechanisms regulating autoimmune and
inflammatory responses, respectively.
Currently, it is not known whether thymic production of autoreactive T cells in general, and
diabetogenic T cells specifically, is a continuous versus time-limited process. The
appearance of prevalent clones as autoimmunity progresses over time (33, 34) may for
instance, reflect continued thymic production of autoreactive T cell clones albeit with
distinct specificities (35). On the other hand, studies employing TCR transgenic mice
specific for thymus-expressed neo-self antigens suggest that the efficiency of negative
selection is reduced in younger animals (36, 37). A “window” may therefore exist early in
life during which the development of autoreactive clones is enhanced, and the pool of anti-
self T cells established. The latter has important implications for understanding the events
that regulate thymic negative selection, in addition to establishing strategies to prevent T
cell-mediated autoimmunity.
We investigated the ontogeny of autoreactive T cells using a thymus transplant approach.
Immunodeficient NOD.scid recipients were implanted with thymus grafts from different
aged NOD donor mice, and the pathogenicity of the resulting T cell pool assessed. Here we
demonstrate that thymic production of organ-specific autoreactive Teff is limited to a 10 d




NOD/LtJ, NOD.CB17-Prkdcscid/J (NOD.scid), and NOD.129S2(B6)-Airetm1.1Doi/DoiJ
(NOD.Airenull) were originally purchased from The Jackson Laboratory (Bar Harbor).
NOD.Cg-Tg(TcrαTcrβBDC2.5)1Doi/DoiJ (NOD.BDC2.5) mice have been previously
described (38). NOD.BDC2.5 mice were bred with NOD.129P2(C)-Tcratm1Mjo/DoiJ
(NOD.Cαnull) mice to generate NOD.BDC2.5.Cαnull mice. All mice were bred and
maintained in specific pathogen-free facilities at the University of North Carolina at Chapel
Hill. Mouse experiments were approved by the University of North Carolina at Chapel Hill
Institutional Animal Care and Use Committee.
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Thymus transplantation and disease assessment
Thymic lobes from newborn (within 48 hr of birth) and various aged female NOD or
NOD.Airenull mice were implanted under the kidney capsule of 6 wk-old female NOD.scid
mice. NOD.scid recipients were monitored for diabetes by measuring blood glucose weekly;
blood glucose levels ≥250 mg/dl (Abbott Diabetes Care Inc) for 2 consecutive
measurements were scored as diabetic. The body weight of animals was measured weekly,
and the development of weight loss was considered as the clinical onset of colitis.
Immunohistological analyses
Various tissues were fixed in 10% neutral buffered formalin (Fisher Scientific), paraffin
embedded, and non-overlapping sections prepared and stained with hematoxylin and eosin
(H&E) or Alcian blue. Severity of insulitis and colitis were graded as previously described
(39, 40).
For thymus immunostaining, thymi were frozen in O.C.T. compound (Sakura Finetek USA)
and 7μM sections cut. Sections were fixed and permeabilized in ice cold acetone/methanol
for 5 min, then washed in PBS. Thymus sections were stained with UEA-1*biotin (Sigma
Aldrich) and Troma-1 (anti-cytokeratin-8) (Developmental Studies Hybridoma Bank,
University of Iowa) followed by Streptavidin*PE (eBiosciences) and AlexaFluor*488 goat
anti-rat IgG (Invitrogen); each step was incubated 1hr at room temperature. Montage thymus
images were taken using a Zeiss Axioplan 2 microscope 10x objective, and analyzed with
Slidebook software (Intelligent Imaging Innovations).
T cell analyses
Cells isolated from the spleen, PLN, MLN and colon were stimulated with PMA (50ng/ml)/
ionomycin (1μg/ml) in complete RPMI 1640 medium at 37°C for 4 to 5 hr and Brefeldin A
was included in the culture for the last 2 hr of incubation. Cells were washed, stained with
Abs specific for CD4 (GK1.5), CD8 (53-6.7), CD3 (2C11) and TCRβ (H57). After fixation
and permeabilization using the Fixation/Permeabilization kit (eBioscience), cells were
stained with Abs specific for intracellular IL-17 (TC11-18H10) and IFNγ (XMG1.2).
Foxp3-expressing T cells were stained using an anti-mouse Foxp3 staining kit as per the
manufacturer’s instructions (eBioscience). T cells were stained as previously described (41)
with in house prepared soluble IAg7 multimers covalently linked to BDC mimetic or HEL
peptides or H2Kd tetramers complexed with IGRP or HA peptides (42, 43). Data were
acquired with CyAn flow cytometer (DakoCytomation) and analyzed using FlowJo (Tree
Star Inc.) or Summit (DakoCytomation) software.
Single cell suspensions were prepared from NOD.scid thymus recipients 6 wks post-
transplantation and 5-10×105 cells/well cultured in triplicate in complete RPMI1640 and
100μg/ml cecal bacterial lysate (CBL) (44) prepared from 6 wk-old NOD mice in 96-well
round bottom plates at 37°C for 48 hr. The supernatants were harvested, and IFNγ and IL-17
measured using ELISA kits (eBiosciences) according to the manufacturer’s instructions.
For adoptive transfer experiments, splenocytes were harvested from NOD.scid thymus
recipients 6 wk post-transplantation and CD4+ and CD8+ T cells purified by negative
selection using mouse CD4 or CD8 T Cell Isolation Kits (Miltenyi Biotec). Female
NOD.scid mice 6 wk of age were injected i.p. with 2×106 T cells per mouse, and then
monitored for diabetes, body weight and rectal prolapse. In some experiments T cells were
labeled prior to transfer with CellTrace Violet (Life Technologies) according to the
manufacturer’s instructions.
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Statistical tests were performed using prism 4.0 software (GraphPad). Body weight data
were analyzed using the Two-way ANOVA. Kaplan-Meier Long-Rank Test was used to
analyze the incidence of diabetes and colitis. Student’s t test and ANOVA were used for all
other data.
RESULTS
Development of diabetes is restricted to a narrow postnatal thymic age
Thymic structural organization differs with ontogeny; the newborn thymus is characterized
by small “islands” of medullary tissue whereas the medulla “coalesces” into a large, well
organized structure with age (Fig. 1A). To assess the ontogeny of β cell-specific T cells,
NOD.scid mice were engrafted under the kidney capsule with thymi from newborn and
older NOD female mice, which represent different stages of T1D. Mature T cells were
detected in the blood of thymus recipients as early as 1 wk post-implantation; by 4-6 wk
~40% of mononuclear cells consisted of CD4+ T cells in recipients of newborn and adult
thymi (Fig. 1B). The reconstitution of CD8+ T cells, however, was delayed in adult versus
newborn thymus recipients (Fig.1B).
Overt diabetes was detected in all NOD.scid mice receiving newborn thymi, and islets
exhibited significant insulitis indicating T cell-mediated β cell destruction (Fig. 1C,D; Table
I). Recipients of 7 and 10 d-old thymi remained diabetes-free; insulitis, however, was
detected albeit at a reduced severity relative to newborn thymus recipients (Fig. 1C; Table
I). In contrast, NOD.scid recipients of thymi from 2 wk and older NOD donors failed to
develop both insulitis and diabetes (Fig. 1C,E; Table I). Similarly, the salivary gland and
thyroid were infiltrated in recipients of newborn and 7 d thymi (Fig. 1I,K; Table I) but not
10 d or older thymi (Fig. 1J,L; Table I).
Surprisingly, symptoms of colitis such as weight loss (Fig. 1F), diarrhea, and rectal prolapse
were detected in NOD.scid mice implanted with 10 d and older thymi. Histologic
examination of the gastrointestinal tract further revealed severe colitis (Fig. 1F; Table I)
based on colonic hyperplasia, inflammation of the mucosal layer, significant infiltration of
the lamina propria by mononuclear cells, and the depletion of goblet cells in the crypts (Fig.
1G,H). NOD.scid mice receiving newborn and 7 d thymi, however, exhibited only limited
colitis and no weight loss or rectal prolapse (Fig. 1F; Table I).
Adoptive transfer experiments confirmed the organ-specific nature of pathogenic T cells
developing in the thymus recipients. Splenocytes isolated from recipients of newborn and 7
d thymi readily transferred diabetes but not colitis to NOD.scid mice (Table II). In contrast,
splenocytes from animals receiving 10 d or older thymi developed colitis but not diabetes
(Table II). Together these findings demonstrate that thymic development of diabetogenic
and colitogenic T cells are reciprocally regulated in an age-dependent manner.
β cell-specific Teff are increased in the PLN of newborn thymus recipients
FACS analyses demonstrated that the number of CD4+ and CD8+ T cells was increased ~2
and ~3-fold, respectively, in the spleen, PLN, and MLN of recipients of newborn and 7 d old
thymi versus 10 d and older thymi (Fig. 2A). Furthermore, Teff in these tissues (Fig. 2B),
including the large intestine (Fig. 2C), consisted of IFNγ+ and/or IL-17+ CD4+ T cells, and
IFNγ+ CD8+ T cells independent of thymus age. However, the frequency of IFNγ+ and
IL-17+ CD4+ T cells and IFNγ+ CD8+ T cells was considerably elevated in recipients of 10
d or older thymi versus animals receiving newborn and 7 d-old thymi (Fig. 2B).
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The frequency of β cell-specific CD4+ and CD8+ T cells were measured in the spleen, PLN
and MLN of newborn, 7 and 10 d thymus recipients. IAg7 and H2Kd multimers were used to
detect CD4+ and CD8+ T cells that recognize a BDC mimetic peptide (IAg7-pBDC), and an
islet-specific glucose-6-phosphatase catalytic subunit-related protein peptide (IGRP; H2Kd-
IGRP), respectively. pBDC-specific CD4+ T cells (45) and IGRP-specific CD8+ T cells (24)
are prevalent diabetogenic clonotypes in NOD mice. The highest frequency of CD4+ and
CD8+ T cells staining with IAg7-pBDC and H2Kd-IGRP, respectively, were detected in the
PLN of newborn thymus recipients (Fig. 2D). Notably, the frequency of IAg7-pBDC+ CD4+
T cells and H2Kd-IGRP+ CD8+ T cells progressively declined in the PLN of 7 d and 10 d
thymus recipients (Fig. 2D).
To examine temporal changes in antigen reactivity of colitogenic T cells, splenocytes
prepared from thymus recipients were stimulated with CBL and IL-17 and IFNγ secretion
measured. IL-17 and IFNγ secretion in response to CBL was substantially increased in
cultures from animals receiving thymi from 10 d and older NOD donors (Fig. 3A). CBL also
induced IL-17 and IFNγ secretion in cultures prepared from newborn and 7 d thymus
recipients albeit at significantly reduced levels (Fig. 3A), despite increased T cell numbers
(Fig. 2A). CD4+ T cells alone from adult thymus recipients were sufficient to transfer
diabetes (Fig. 3B). The importance of T cell reactivity to colonic microbiota in the
development of colitis was further demonstrated in NOD.scid recipients of thymi from 6
wk-old NOD.BDC2.5 versus NOD.BDC2.5.Cαnull donors. Severe colitis developed in
NOD.scid recipients of NOD.BDC2.5 thymus (Fig. 3C), in which T cells expressed both the
BDC2.5 clonotypic and endogenous TCR. On the other hand, severity of colitis was
markedly reduced in NOD.scid recipients when the specificity of NOD.BDC2.5.Cαnull
CD4+ T cells was restricted to the β cell autoantigen chromogranin A (46) (Fig. 3C).
Recipients of NOD.BDC2.5 (or NOD.BDC2.5.Cαnull) thymi, however, developed diabetes
(Fig. 3D) indicating that colitis per se did not block β cell autoimmunity. In sum these
results demonstrate that increased thymic development of β cell-specific T cells is restricted
to a 7 d window after birth. Furthermore development of colitogenic T cells specific for
microbiota is significantly increased at, and maintained after 10 d of age in NOD mice.
Thymus age-dependent development of diabetes is not due to changes in Foxp3+Treg and
immunoregulation in the PLN of recipients
The above data indicated that thymic development of β cell-specific T cells declines with
age resulting in reduced numbers of Teff to mediate diabetes. However, lack of β cell
autoimmunity in recipients of post-newborn thymi may also be due to a reciprocal increase
in Foxp3+Treg residing in the PLN to block expansion of diabetogenic Teff. To distinguish
between these two possibilities, the frequency of Foxp3+Treg was assessed in the spleen,
PLN and MLN of thymus recipients. Interestingly, PLN Foxp3+CD25+CD4+ T cells were
increased in newborn and 7 d versus 10 d and older thymus recipients, whereas the
frequency of spleen and MLN resident Foxp3+CD25+CD4+ T cells was similar independent
of thymic age (Fig. 4A). To assess the immunoregulatory activity in the PLN, NOD.BDC2.5
CD4+ T cells were transferred into recipients of newborn and 4 wk thymi, and proliferation
measured. No marked difference was detected in the level of NOD.BDC2.5 CD4+ T cell
proliferation between the respective thymus recipients (Fig. 4B). These results indicate that
the block in β cell autoimmunity in thymus recipients is not due to an increase in the
Foxp3+Treg pool or immunoregulation in the PLN, but attributed to reduced numbers of β
cell antigen-specific T cells.
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The temporal development of autoreactive T cells occurs in the absence of Aire
expression
Regulation of TSA expression by Aire may contribute to the temporal thymic development
of autoreactive T precursors. To test this possibility the pathology of NOD.scid recipients
transplanted with thymi from different aged NOD mice deficient in Aire expression
(NOD.Airenull) was investigated. NOD.Airenull mice lack β cell autoimmunity but develop
multi-organ T cell-mediated inflammation (47), which includes exocrine pancreatitis.
Tissues normally targeted in NOD.Airenull mice were also infiltrated in NOD.scid recipients
of newborn NOD.Airenull thymi (Fig. 5A, Table III). Strikingly, a progressive decline in T
cell infiltration of the exocrine pancreas and salivary glands was detected in recipients of 7
and 10 d old NOD.Airenull thymi, and no infiltration of these tissues was observed in 4 wk-
old thymus recipients (Fig. 5A, Table III). On the other hand, T cell infiltration continued to
be detected in the eyes, ovaries, stomach and lungs of animals implanted with day 7 and
older NOD.Airenull thymi (Fig. 5A,B). The severity of colitis in the recipients, however, was
limited regardless of NOD.Airenull thymi age (Fig. 5B). These results demonstrate that
temporal regulation of thymic development of autoreactive T cells can occur in the absence
of Aire expression albeit for certain tissue-specificities and not others.
DISCUSSION
The dynamics of and the parameters that influence thymic output of autoreactive T cells are
poorly understood. To address these issues a thymus transplant model system was
employed. This approach provides a “snapshot” of the specificities of autoreactive T cells
produced in the thymus at a given age.
We demonstrate that thymic production of β cell-specific T cells is regulated in a temporal
manner in NOD mice. Insulitis and diabetes developed in recipients of NOD newborn thymi
(Fig. 1C,D), which corresponded with an increased frequency of PLN-resident pBDC-
specific CD4+ and IGRP-specific CD8+ T cells (Fig. 2D), 2 major clonotypes associated
with the progression of β cell autoimmunity in NOD mice. These results are consistent with
findings demonstrating that NOD mice develop diabetes with normal kinetics and incidence
despite thymectomy 3 d after birth, indicating that a sufficient pool of diabetogenic T cells is
established early in ontogeny (48). Interestingly, autoimmunity has been reported in
immunodeficient children with congenital athymia receiving a human infant thymus
transplant (49). Noteworthy was the progressive decline in insulitis (Fig. 1C) and the
frequency of β cell-specific T cells in recipients of 7 and 10 d old NOD thymi (Fig. 2D).
This reduction in β cell-specific T cells was not due to a reciprocal increase in the pool of
PLN-resident Foxp3+Treg or enhanced tissue-specific immunoregulation that would be
expected to block the expansion of diabetogenic Teff (Fig. 4). Furthermore, colitis per se
had no suppressive effect on β cell autoimmunity. For instance, both diabetes and colitis
were detected in NOD.scid mice receiving NOD.BDC2.5 thymi (Fig. 3C,D) or a mixture of
splenocytes from colitogenic and diabetic donor animals (Fig. S1), showing that the
progression of the 2 pathologies is independent and not mutually exclusive. Together these
findings indicate that the lack of insulitis and diabetes, and reduced frequency of
diabetogenic T cells in recipients of post-newborn thymi is the result of diminished thymic
production of β cell-specific T cells. Importantly, thyroiditis and sialitis detected in newborn
thymus recipients were also reduced in recipients of 7 and 10 d-old thymi (Fig. 1I-L, Table
I) demonstrating that thymic production of autoreactive T cells in general is regulated in an
age-dependent manner.
To explain the temporal decline in autoreactive T cell production we favor a model in which
the efficacy of thymic negative selection increases during postnatal life. Several mutually
nonexclusive possibilities may account for this effect. Reduced expression of TSA due to
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limiting Aire expression may lead to inefficient thymic negative selection of autoreactive T
cells in the neonatal thymus (12, 16, 18). Indeed, both the frequency of Aire-expressing
mTEC, and mRNA expression of Aire-dependent TSA genes such as Ins2 are reduced in
thymi from newborn versus older NOD mice (R.T. & C.J.K; unpublished data).
Furthermore, Guerau-de-Arellano and colleagues reported that induced expression of Aire
and corresponding TSA by mTEC during embryonic life and up to 21 d after birth was
critical to block the multi-organ autoimmunity typical of NOD.Airenull mice (50). Our
observation that recipients developed significant infiltration of the ovaries, stomach, lungs
and eyes implanted with newborn and older NOD.Airenull thymi (Fig. 5, Table III) supports
a role for Aire in the temporal development of these tissue-specific T cells. Strikingly,
however, exocrine pancreatitis and sialadenitis failed to develop in recipients of thymi from
10 d or older NOD.Airenull donors (Fig. 5, Table III) suggesting that Aire-dependent TSA
expression alone does not account for the observed temporal production of autoreactive T
cells specific for these tissues. Age-dependent changes in the stimulatory capacity of the
thymic APC pool, due to the number, composition and/or maturation status of mTEC and
thymic DC may contribute to the efficiency of thymic negative selection (18, 50-52).
Alternatively, the development of autoreactive T cells may reflect intrinsic properties of T
cell progenitors residing in the thymus during ontogeny. For example, studies have shown
that hematopoietic stem cells that seed the thymus at various stages of ontogeny give rise to
T cells with distinct properties and antigen specificity (53-56). The latter may influence the
affinity and/or cross-reactivity or promiscuity of TCR specific for TSA-derived epitopes that
are either Aire- dependent or -independent. Finally, major changes in the structural
organization of the medulla seen during postnatal life may impact the efficiency of negative
selection. The rudimentary thymus of newborn animals (Fig. 1A) may limit thymocyte
interactions with medullary resident APC thereby reducing the efficiency of negative
selection, particularly if given TSA are expressed and presented at relatively low levels.
Efforts are ongoing to delineate what is likely to be a complex interplay between multiple
events that regulate the temporal efficiency of thymic negative selection.
An interesting observation made in this study was that thymic development of colitogenic T
cells was also temporally regulated. Negligible colitis was detected in recipients of newborn
and 7 d NOD thymi (Fig. 1F). However, severe colitis developed in recipients of thymi from
NOD donors 10 d of age and older (Fig. 1F) which was marked by an increased number and
frequency of IL-17 and IFNγ producing CD4+ T cells specific for CBL (Fig. 2B). Unlike β
cell-specific T cells, which were selectively increased in the PLN (Fig. 2D), CBL reactivity
was readily detected in all tissues examined (Fig. 3A), likely reflecting systemic trafficking
of a relatively large pool of colitogenic Teff. Recognition of commensal microbiota antigen
was necessary for colitis; recipients of thymi from NOD.BDC2.5.Cαnull donors which
express chromogranin A-specific TCR (46) failed to develop significant colitis (Fig. 3B). In
contrast, increased colitis was detected in animals receiving thymi from adult NOD.BDC2.5
mice, which co-express transgenic and endogenous TCR (Fig. 3B). These findings
demonstrate that in addition to autoreactive T cells, the development of T cells specific for
exogenous (e.g. microbial) antigens is regulated temporally, but in a reciprocal relationship
to autoimmune T cells. In this instance, production of T cells specific for microbial antigens
is enhanced after postnatal life, suggesting an increase in the efficiency of thymocyte
positive selection. In addition, colitis was detected in NOD.scid recipients of thymi from 12
wk-old C57BL/6 mice congenic for H2g7 (Fig. S2), suggesting that thymic development of
colitogenic T cells is independent of the NOD genotype. These results further support the
prevailing concept that chronic immune-mediated colitis is driven by microbial-responsive T
cells rather than autoimmune responses (57).
Since T cell reconstitution occurred under identical conditions in NOD.scid recipients,
lymphopenic expansion cannot explain the temporal development of autoreactive and
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colitogenic T cell repertoires. It is likely, however, that lymphopenia favored the
differentiation of pathogenic Teff driving autoimmunity and colitis. Development of
autoreactive T cells that is largely restricted to early ontogeny further underscores the role of
peripheral mechanisms in maintaining life-long self-tolerance. Our findings may also in part
explain the long-lasting and robust tolerance typically induced by administration of self-
antigen to neonates (58-60). Here, deletion early in ontogeny would be expected to
permanently purge the corresponding autoreactive clonotype(s) from the immune system.
In conclusion, our results demonstrate that thymic development of T cells specific for self
and foreign antigens is tightly regulated over a short ontogenic time window. These findings
also indicate that the pool of β cell (and other tissue)-specific T cells is to a large extent
established early in ontogeny. A number of coordinated events within the thymus are likely
to contribute to the temporal development of autoreactive and bacterial antigen-responsive T
cells in a reciprocal manner. Exploiting the use of the thymus transplant model provides a
novel approach to better define these events.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Reciprocal development of diabetes and colitis in NOD.scid recipients is dependent on
the age of NOD donor thymus
(A) Cytokeratin-8 (green, cortex) and UEA-1 (red, medulla) immunostaining of sections
from newborn, 7 d-, 10 d-, and 4 wk-old NOD thymi; images were taken at 100X
magnification. (B) NOD.scid mice were engrafted with thymi from newborn (NB) or 12 wk-
old (n=10) NOD female donors and the frequency of CD4+ (left panel) and CD8+ (right
panel; *p<10-4) T cells measured in peripheral blood. (C) Diabetes (left panel; *p<10-4
versus recipients of 7 d or older thymi; Kaplan-Meier Log Rank) and the frequency of
insulitis (right panel; n=8; *p<10-4; Student’s t test) in thymus recipients; representative
H&E staining of pancreatic sections of recipients of newborn (D) and 12 wk-old thymi (E).
(F) Body weight (left panel; *p<10-4; 2-way ANOVA) and colitis scores (right panel;
*p<10-4; Student’s t test) of recipients (n=8) of different aged thymi and control NOD.scid
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littermates. Representative Alcian blue stained colonic sections of recipients of newborn (G)
and 12 wk-old (H) thymi. Representative H&E staining of thyroid (I,J) and salivary (K,L)
glands from newborn (I,K) and 12 wk-old (J,L) thymus recipients. Error bars represent
SEM.
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Figure 2. Distinct T cell phenotypes and specificities detected in recipients of different aged NOD
donor thymi
The spleen, PLN and MLN of different aged NOD thymus recipients 8 wk-post implantation
and control 12 wk-old intact NOD female mice (NOD) were assessed via FACS for (A)
CD3+CD4+ and CD3+CD8+ T cell numbers (n=7; *p<10-2; Student’s t test), (B) the
frequency of intracellular IFNγ and IL-17 expressing CD4+ and CD8+ T cells (n=7;
*p<0.005; Student’s t test). (C) Representative FACS plots (left and center) and frequency
of IL-17 producing T cells isolated from the large intestines of newborn and 12 wk-old
thymus recipients; gated on CD3+CD4+ T cells (n=7; *p<0.05; Student’s t test). (D) The
frequency of IAg7-pBDC-binding CD4+ T cells and H2Kd-IGRP-binding CD8+ T cells with
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representative FACS plots from PLN isolated cells; gated on CD3+ and CD4+ or CD8+ T
cells respectively (n=5; *p<0.05; Student’s t test). Error bars represent SEM.
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Figure 3. Colitogenic T cells respond to intestinal microbial antigens
(A) Secretion of IFNγ and IL-17 by isolated T cells stimulated with CBL, as measured by
ELISA, in the spleen, PLN, and MLN of recipients of different aged thymi 8 wk post-
implantation (n=7; *p<10-4; Student’s t test). (B) Splenic CD4+ and CD8+ T cells isolated
from NOD.scid thymus recipients 8 wk post-implantation, and adoptively transferred into
NOD.scid mice, which were monitored for body weight loss (left panel; *p<0.05, 2-way
ANOVA) and development of rectal prolapse (right panel; *p<0.05, 2-way ANOVA). (C)
Representative colonic sections stained with Alcian blue, and colitis scores (*p<0.05;
Student’s t test) and (D) diabetes incidence for recipients (n=5) of thymi from 6 wk-old
NOD.BDC2.5 and NOD.BDC2.5Cαnull donors. Error bars represent SEM.
He et al. Page 16













Figure 4. Development of diabetes is not due to increased Foxp3+Treg frequency or suppression
(A) Frequency of Foxp3+CD25+CD4+ T cells in recipients of different aged NOD thymi
(n=7) 6 wk-post implantation or 12 wk-old intact NOD female mice (NOD). (B) In vivo
proliferation of cell trace-labeled NOD.BDC2.5 CD4+ T cells 4 d post-transfer in the PLN
of recipients of newborn and 4 wk-old NOD thymus 6 wk post-implantation or
unmanipulated NOD.scid controls. Data is reported as proliferation index (left) with
representative FACS histograms gated on CD3+CD4+cell trace+ T cells (right) (n=5). Error
bars represent SEM.
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Figure 5. Temporal development of autoreactive T cells is independent of Aire in some organs
NOD.scid mice received thymi from different aged NOD.Airenull donors. (A)
Representative H&E stained sections of organs; arrows highlight areas of infiltration. (B)
colitis scores of different aged NOD.Airenull thymus recipients (n=5). Error bars represent
SEM.
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Table I
T cell infiltration of organs in NOD.scid recipients of different aged NOD thymi.
Pancreas L. Intestine Salivary Gland Thyroid
NB 5/5 0/5 5/5 5/5
7 d 5/6 0/6 6/6 6/6
10 d 0/7 7/7 0/7 4/7
2 wk 0/6 6/6 0/6 0/7
4 wk 0/7 7/7 0/7 0/7
6 wk 0/6 6/6 0/6 0/6
12 wk 0/13 13/13 0/13 0/13
*
Thymi from various aged female NOD mice were transplanted under the kidney capsule of 6 week old NOD.scid recipients; L. Intestines denotes
large intestines
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Table II




7 d 5/6 0/6
10 d 0/7 7/7
2 wk 0/6 6/6
4 wk 0/7 7/7
6 wk 0/6 6/6
12 wk 0/13 13/13
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Table III
Relative T cell infiltration of organs in NOD.scid recipients of different aged NOD.Airenull thymi.
NB Airenull 7 d Airenull 10 d Airenull 4 wk Airenull
Pancreas +++ ++ + -
Ovary +++ +++ +++ ++
L. Intestines + + + +
Stomach ++ ++ ++ ++
Lung ++ ND ND ++
Salivary Gland ++ ++ + -
Cecum + + + +
S. Intestines + + + +
Eyes +++ ND ND +++
*
Infiltration of various organs in NOD.scid recipients of various aged thyme from NOD.Airenull donors. “+++” = heavy/complete T cell
infiltration; “++” = moderate T cell infiltration; “+” = mild T cell infiltration; “-“ indicates an absence of infiltration; ND = “not observed”; L.
Intestines denotes large intestines; S. Intestines denotes small intestines
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